Casey Woodring
Stock Analyst at JP Morgan
(0.69)
# 4,020
Out of 5,044 analysts
40
Total ratings
30.43%
Success rate
-14.96%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Downgrades: Neutral | $78 | $74.01 | +5.39% | 6 | Oct 22, 2025 | |
| WAT Waters | Maintains: Neutral | $300 → $325 | $345.95 | -6.06% | 1 | Oct 9, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $600 → $650 | $557.63 | +16.56% | 1 | Oct 9, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,200 → $1,285 | $1,404.58 | -8.51% | 1 | Oct 9, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $155 → $165 | $145.85 | +13.13% | 1 | Oct 9, 2025 | |
| GH Guardant Health | Maintains: Overweight | $60 → $70 | $69.58 | +0.60% | 1 | Sep 25, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $145 → $160 | $187.93 | -14.86% | 8 | Aug 7, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $265 → $150 | $177.73 | -15.60% | 6 | Apr 29, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $38 → $25 | $28.19 | -11.32% | 4 | Apr 21, 2025 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $47.95 | +16.00% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.87 | +109.06% | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $23 | $17.58 | +30.83% | 2 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $18 | $16.56 | +8.70% | 2 | Jan 23, 2023 |
Hologic
Oct 22, 2025
Downgrades: Neutral
Price Target: $78
Current: $74.01
Upside: +5.39%
Waters
Oct 9, 2025
Maintains: Neutral
Price Target: $300 → $325
Current: $345.95
Upside: -6.06%
Thermo Fisher Scientific
Oct 9, 2025
Maintains: Overweight
Price Target: $600 → $650
Current: $557.63
Upside: +16.56%
Mettler-Toledo International
Oct 9, 2025
Maintains: Neutral
Price Target: $1,200 → $1,285
Current: $1,404.58
Upside: -8.51%
Agilent Technologies
Oct 9, 2025
Maintains: Overweight
Price Target: $155 → $165
Current: $145.85
Upside: +13.13%
Guardant Health
Sep 25, 2025
Maintains: Overweight
Price Target: $60 → $70
Current: $69.58
Upside: +0.60%
Charles River Laboratories International
Aug 7, 2025
Maintains: Neutral
Price Target: $145 → $160
Current: $187.93
Upside: -14.86%
ICON Public Limited Company
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $177.73
Upside: -15.60%
QuidelOrtho
Apr 21, 2025
Maintains: Underweight
Price Target: $38 → $25
Current: $28.19
Upside: -11.32%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $47.95
Upside: +16.00%
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.87
Upside: +109.06%
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $17.58
Upside: +30.83%
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $16.56
Upside: +8.70%